Skip to content

Tenofovir may linger up to 3 weeks in body: discontinue with caution

Travelling on HAART, particularly to the US, a 'negative practical and emotional experience.'

BHIVA issues draft 2005 treatment guidelines, calls for comments by May 3rd

A quarter of US women stop HAART within five years

HAART can be safely interrupted for over a year by patients with lowest ever CD4 cell count above 250 and a sustained treatment CD4 cell count of 500 or more

Therapeutic vaccine plus interleukin-2 shows best viral control in treatment breaks

CD4-guided structured treatment interruptions safe in patients at high risk of resistance

Lowest-ever CD4 cell count can predict how long treatment can be interrupted

ICAAC: Treatment breaks riskier if NNRTIs involved